Cris P Lanting

9PUBLICATIONS
37CO-AUTHORS
Nanotoxicology, health and safetyTranslation and interpretation studiesSensory processes, perception and performanceCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 11, 2025
Assessment of Safety, Tolerability, Pharmacokinetics, and Volume-Dependent Conductive Hearing Loss in Healthy Volunteers: First-in-Human, Open-Label, Placebo-Controlled Study of a Single Intratympanic Injection of AC102.

Cris Lanting, Sybren Robijn, Michael Nieratschker

|Apr 23, 2025
Cochlear Implantation Outcomes in Genotyped Subjects with Sensorineural Hearing Loss.

M L A Fehrmann, L Haer-Wigman, H Kremer

|Sep 13, 2024
Evaluating cochlear implant outcomes in DFNA9 subjects: a comprehensive study on cerebral white matter lesions and vestibular abnormalities.

M L A Fehrmann, F J A Meijer, E A M Mylanus

|Sep 06, 2024
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer.

A V M Burger, C W Duinkerken, K E van Sluis

|Feb 25, 2023
Genotype and Phenotype Analyses of a Novel <i>WFS1</i> Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38.

Hedwig M Velde, Xanne J J Huizenga, Helger G Yntema

|Feb 28, 2022
Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.

Hedwig M Velde, Janine Reurink, Sebastian Held

Pageof 2

Frequent Collaborators

7 joint publications

Ronald J E Pennings

6 joint publications

Hannie Kremer

3 joint publications

Lonneke Haer-Wigman

2 joint publications

Frans P M Cremers